Letter

Authors' reply

BMJ 1994; 309 doi: 10.1136/bmj.309.6967.1512 (Published 3 December 1994)
Cite this as: BMJ 1994;309:1512.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Eric S Kilpatrick,
  2. Alan G Rumley,
  3. Marek H Dominiczak,
  4. Michael Small
  1. Career registrar Principal biochemist Consultant biochemist Department of Pathological Biochemistry, Gartnavel General Hospital, Glasgow G12 0YN Consultant physician Diabetic Unit, Gartnavel General Hospital.

    EDITOR,—A S Wierzbicki and colleagues think that trends in glycated haemoglobin concentration should be used with little referral to their absolute value. Accordingly, they must think that a patient with a stable haemoglobin A1c concentration of 12% should be treated in a similar manner to one with a stable value of 6%. In the light of the diabetes control and complications trial, which showed an impressive reduction in microvascular complications with improved absolute glycated haemoglobin values,1 …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular